LONDON, Ontario — A U.S. drug company says it wants to market its chicken pox vaccine in Canada.
Merck and Co. won approval from the U.S. Food and Drug Administration to sell the vaccine in the United States last year. A similar application to Health Canada will be made by Merck’s Canadian subsidiary, Merck Frosst Canada Inc., within a year, said spokesman Allister MacDonald.
Although chicken pox is usually mild, 762 people in Canada required hospital care and there was one death out of 17,788 reported cases in 1991 and 1992. The disease is highly contagious.